dcterms.isReferencedBy |
Arioz, D.T., Altindis, M., Tokyol, C., Human papillomavirus typing and soluble interleukin-2 receptor levels in female sex workers with a negative cervical smear result (2009) Int J of Gynaecol Obstet, 106, pp. 210-212; Bien, E., Balcerska, A., Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma (2009) Scand J Immunol, 70, pp. 490-500; Bien, E., Balcerska, A., Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review (2008) Biomarkers, 13, pp. 1-26; Bien, E., Balcerska, A., Interleukin 2 receptor-the structure, function and clinical significance in malignant diseases of adults and children (2003) Postepy Hig Med Dosw, 57, pp. 669-683; Brito-Babapulle, F., The eosinophilias, including the idiopathic hypereosinophilic syndrome (2003) Br J Haematol, 121, pp. 203-223; Cervera, I., Herraiz, M.A., Pe�aloza, J., Vidart, J., Martinez-Laso, J., A new allele, HLA-G010120, is generated by a recombination event between HLA-G*01010101/02 and HLA-G*01010201 (2010) Tissue Antigens, 75, pp. 738-740; Eiji, O., Tasuke, H., Katsumi, O., Clinical utility of soluble interleukin-2 receptor in patients with acute lymphoblastic leukemia (2000) Jpn J Med Technol, 49, pp. 1576-1579; Elattar, I., (2007) Cancer statistics, , NCI, Egypt 2002-2005; Faderl, S., O'brien, S., Pui, C.H., Adult acute lymphoblastic leukemia: concepts and strategies (2010) Cancer, 1, pp. 1165-1176; Fainardi, E., Castellazzi, M., Stignani, M., Emerging topics and new perspectives on HLA-G (2011) Cell Mol Life Sci, 68, pp. 433-451; Garc�a-Tu��n, I., Ricote, M., Ruiz, A., Interleukin-2 and its receptor complex (?, ? and ? chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study (2004) Breast Cancer Res, 6, pp. 1-7; Gonz�lez, A., Rebmann, V., LeMaoult, J., The immunosuppressive molecule HLA-G and its clinical implications (2012) Crit Rev Clin Lab Sci, 49, pp. 63-84; Hafiz, M.G., Rahman, M.M., Mannan, M.A., Serum lactate dehydrogenase as a prognostic marker of childhood acute lymphoblastic leukemia (2008) Mymensingh Med J, 17, pp. 169-173; HoWangYin, K., Caumartin, J., Favier, B., Proper regrafting of Ig-like transcript 2 after trogocytosis allows a functional cell-cell transfer of sensitivity (2011) J Immunol, 186, pp. 2210-2218; HoWangYin, K.Y., Alegre, E., Daouya, M., Different functional outcomes of intercellular membrane transfers to monocytes and T cells (2010) Cell Mol Life Sci, 67, pp. 1133-1145; Jo, S.A., Hwang, S.H., Chang, C.L., Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Ra) in patients with non-Hodgkin's lymphoma (2010) Korean J Lab Med, 30, pp. 600-605; Kasprzak, A., Olejniczak, K., Przybyszewska, W., Zabel, M., Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours (2007) Folia Morphol (Warsz), 66, pp. 159-166; Katsuya, H., Yamanaka, T., Ishitsuka, K., Prognostic index for acute- and lymphoma-type adult T-cell leukemia/ lymphoma (2012) J Clin Oncol, 30, pp. 1635-1640; Kitaoka, S., Shiota, G., Kawasaki, H., Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C (2003) Hepatogastroenterology, 50, pp. 1569-1574; Ksouri, H., Bardi, R., Mellouli, F., Bejaoui, M., HLA-G: an immunoregulatory non classical class I HLA molecule (2009) Arch Inst Pasteur Tunis, 86, pp. 27-38; Le Discorde, M., Moreau, P., Sabatier, P., Legeais, J.M., Carosella, E.D., Expression of HLA-G in human cornea, an immune-privileged tissue (2003) Hum Immunol, 64, pp. 1039-1044; Ling, J.Y., Sun, X.F., Yan, S.L., Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases (2007) Ai Zheng, 26, pp. 418-422; Mallet, V., Blaschitz, A., Crisa, L., HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83 dendritic cells expresses HLA-G as a membranebound and soluble protein (1999) Int Immunol, 11, pp. 889-898; Mitsdoerffer, M., Schreiner, B., Kieseier, B.C., Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis (2005) J Neuroimmunol, 159, pp. 155-164; Moon, Y., Kim, Y., Kim, M., Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia (2004) Ann Clin Lab Sci, 34, pp. 410-415; Nakase, K., Tsuji, K., Tamaki, S., Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies (2005) Cancer Detect and Prev, 29, pp. 256-259; Pavlidis, N.A., Manoussakis, M.N., Germanidis, G.S., Moutsopoulos, H.M., Serum soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies (1992) Med Pediatr Oncol, 20, pp. 26-31; Pistoia, V., Morandi, F., Wang, X., Ferrone, S., Soluble HLA-G: Are they clinically relevant (2007) Semin Cancer Biol, 17, pp. 469-479; Pui, C.H., Acute lymphoblastic leukemia, in Childhood Leukemias, 2nd ed (2006) In: Pui CH, p. 439. , Cambridge University Press New York; Pui, C.H., Evans, W.E., Treatment of acute lymphoblastic leukemia (2006) N Engl J Med, 354, pp. 166-178; Rebmann, V., Switala, M., Eue, I., Grosse-Wilde, H., Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study (2010) Hum Reprod, 25, pp. 1691-1698; Rizzo, R., Vercammen, M., van de Velde, H., Horn, P.A., Rebmann, V., The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells (2011) Cell Mol Life Sci, 68, pp. 341-352; Rouas-Freiss, N., Moreau, P., Ferrone, S., Carosella, E.D., HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism? (2005) Cancer Res, 65, pp. 10139-10144; Sarmento-Ribeiro, A.B., Proen�a, M.T., Sousa, I., A possible role for oxidation stress in lymphoid leukaemias and therapeutic failure (2012) Leuk Res, 36, pp. 1041-1048; Sheshgiri, R., Rao, V., Mociornita, A., Ross, H.J., Delgado, D.H., Association between HLA-G expression and C4d staining in cardiac transplantation (2010) Transplantation, 89, pp. 480-481; Singer, G., Rebmann, V., Chen, Y.C., HLA-G is a potential tumor marker in malignant ascites (2003) Clin Cancer Res, 9, pp. 4460-4464; Wehner, R., Dietze, K., Bachmann, M., Schmitz, M., The bidirectional crosstalk between human dendritic cells and natural killer cells (2011) J Innate Immun, 3, pp. 258-2563; Wiendl, H., Feger, U., Mittelbronn, M., Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity (2005) Brain, 128, pp. 2689-2704; Yan, W.H., HLA-G expression in hematologic malignancies (2010) Expert Rev Hematol, 3, pp. 67-80; Yang, J., Zhao, S.L., Yang, X.L., (2012) Expression of HLA-G and, , http://dx.doi.org/10.7314/APJCP.2012.13.11.5399, DOI; sHLA-G and sILs-2R Levels in Childhood Acute Leukemia Patients IL-10 in patients with acute leukemia Zhonghua Xue Ye Xue Za Zhi, 33, pp. 135-137 |
|